Research and Innovation to strengthen Europe's industrial capacities and business perspectives, including Small and Medium Sized Enterprises (SMEs).
mark.antonissen@vlaio.be
+32 2 432 43 05
Research and Innovation to strengthen Europe's industrial capacities and business perspectives, including Small and Medium Sized Enterprises (SMEs).
The Leadership in Enabling and Industrial Technologies (LEIT) part of Horizon 2020 will support the development of technologies underpinning innovation across a range of sectors. Horizon 2020 will have a strong focus on developing European industrial capabilities in Key Enabling Technologies (KETs).
This part of the programme covers different areas :
Activities of the work programme will address the whole innovation chain with technology readiness levels spanning the crucial range from medium levels to high levels preceding mass production, and helping to bridge the gaps ("valley of death") in this range. These activities will be based on research and innovation agendas defined by industry and business, together with the research community, and have a strong focus on leveraging private sector investment.
For the higher technology readiness levels, dedicated support will therefore be provided for larger-scale pilot lines and demonstrator projects to facilitate industrial take-up and commercialisation. There will be a strong focus on the contribution of Key Enabling Technologies to societal challenges.
Interested in our testimonies?
Click here
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.